<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: BIOS Fund II, LP -->
          <cik>0001714576</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001763950</issuerCik>
      <issuerName>Lantern Pharma Inc.</issuerName>
      <secFileNumber>001-39318</secFileNumber>
      <issuerAddress>
        <com:street1>1920 MCKINNEY AVENUE, 7TH FLOOR</com:street1>
        <com:city>DALLAS</com:city>
        <com:stateOrCountry>TX</com:stateOrCountry>
        <com:zipCode>75201</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972-277-1136</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Bios Fund II, LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate (10% owner)</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Sanders Morris Harris</name>
        <address>
          <com:street1>5950 Sherry Lane, Ste 470</com:street1>
          <com:city>Dallas</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>75225</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>30650</noOfUnitsSold>
      <aggregateMarketValue>119841.50</aggregateMarketValue>
      <noOfUnitsOutstanding>10664803</noOfUnitsOutstanding>
      <approxSaleDate>02/27/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>06/15/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Conversion of Shares in IPO</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>221522</amountOfSecuritiesAcquired>
      <paymentDate>06/15/2020</paymentDate>
      <natureOfPayment>Conversion</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Bios Fund II, LP</name>
        <address>
          <com:street1>1751 River Run</com:street1>
          <com:street2>Suite 400</com:street2>
          <com:city>Fort Worth</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76107</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>02/27/2024</saleDate>
      <amountOfSecuritiesSold>10620</amountOfSecuritiesSold>
      <grossProceeds>46697.20</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>02/28/2024</noticeDate>
      <signature>/s/ Daniel Schwarz</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
